These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 2418117)

  • 21. Immunotherapeutic elimination of syngeneic tumors in vivo by cytotoxic T lymphocytes generated in vitro from lymphocytes from the draining lymph nodes of tumor-bearing mice.
    Lynch DH; Miller RE
    Eur J Immunol; 1991 Jun; 21(6):1403-10. PubMed ID: 1904359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphism and tissue distribution of maternally transmitted antigen defined by cytotoxic T lymphocyte lines.
    Smith R; Rich RR
    J Immunol; 1985 Apr; 134(4):2191-7. PubMed ID: 2579132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic T lymphocyte recognition of a xenogeneic major histocompatibility complex antigen expressed in transgenic mice.
    Bluestone JA; Pescovitz MD; Frels WI; Singer DS; Hodes RJ
    Eur J Immunol; 1987 Jul; 17(7):1035-41. PubMed ID: 2440691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of in vitro cytotoxic T lymphocyte generation. III. Interactions or regulatory T cell subsets in suppressor and target populations.
    Schwartz A; Gershon RK
    J Mol Cell Immunol; 1984; 1(4):237-52. PubMed ID: 6152894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of alloreactive cytotoxic T cells by acute virus infection of mice.
    Yang H; Welsh RM
    J Immunol; 1986 Feb; 136(4):1186-93. PubMed ID: 2418107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultraviolet light induces tumors with both unique and host-associated antigenic specificities.
    DeWitt CW
    J Immunol; 1981 Jul; 127(1):329-34. PubMed ID: 6165770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Class II antigen-specific murine cytolytic T lymphocytes (CTL). II. Genuine class II specificity of Lyt-2+ CTL clones.
    Shinohara N; Hozumi N; Watanabe M; Bluestone JA; Johnson-Leva R; Sachs DH
    J Immunol; 1988 Jan; 140(1):30-6. PubMed ID: 3257229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactive recognition of mouse cells expressing the bm3 and bm11 mutations within H-2Kb by H-2Kb-restricted herpes simplex virus-specific cytotoxic T lymphocytes.
    Jennings SR
    J Immunol; 1985 Nov; 135(5):3530-6. PubMed ID: 2413124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Participation of a dominant cytotoxic T cell population defined by a monoclonal antibody in syngeneic anti-tumor responses.
    Matsubayashi Y; Hirama T; Morioka A; Iwashiro M; Masuda T; Uchino H; Takeshita S; Yamagishi H; Udono H; Mieno M
    Eur J Immunol; 1990 Sep; 20(9):2095-103. PubMed ID: 1698639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen.
    Ishikawa H; Hino T; Kato H; Suzuki H; Saito K
    J Immunol; 1986 Oct; 137(7):2080-8. PubMed ID: 3489752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of cytotoxic T cells specific for minor histocompatibility antigens by cross challenge in vitro with H-2 disparate adherent cells.
    Pilarski LM; Carayanniotis G
    J Immunol; 1985 Dec; 135(6):3686-90. PubMed ID: 2415580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of the immune response to tumor antigens. IX. In vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen.
    Carter RH; Drebin JA; Schatten S; Perry LL; Greene MI
    J Immunol; 1983 Feb; 130(2):997-1002. PubMed ID: 6184410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction.
    Kosmatopoulos K; Algara DS; Orbach-Arbouys S
    J Immunol; 1987 Feb; 138(4):1038-41. PubMed ID: 3492538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
    Yang HY; Dundon PL; Nahill SR; Welsh RM
    J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.